CD38 and diffuse large B-cell lymphoma: While MM cell lines with high levels of CD38 expression were more susceptible to isatuximab-mediated cytotoxicity through ADCC and ADCP, DLBCL cells were more sensitive to isatuximab-induced apoptosis and ADCC.